Tag: fibrocell

December 10, 2018

Genetics Outlook 2019: CRISPR Technology Advances

With 2018 coming to a close, here's a look at the biggest genetics trends of the year and what's in...
March 19, 2018

Fibrocell Reports 2017 Financial Results and Recent Highlights

Fibrocell Science (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today...
March 6, 2018

Fibrocell Announces FDA Allowance of Investigational New Drug Application for FCX-013

Fibrocell Science (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today...
February 5, 2018

Fibrocell Announces Submission of Investigational New Drug Application for FCX-013

Fibrocell Science (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today...
January 30, 2018

Fibrocell Announces FDA Allowance to Initiate Pediatric Enrollment in Phase 1/2 Clinical Trial

Fibrocell Science (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue, today announced...
September 26, 2017

Fibrocell Reports Interim Results of Phase 1/2 Clinical Trial of FCX-007

Fibrocell Science reported interim results in its Phase 1/2 clinical trial of FCX-007 for the treatment of recessive dystrophic epidermolysis...
January 5, 2017

Genetics Outlook 2017: The Revolution Nears

You've heard it before ... but this time, it really does look like the gene therapy revolution is drawing near.